Babak Bohlouli1, Marcello Tonelli2, Terri Jackson3, Brenda Hemmelgam3, Scott Klarenbach4. 1. Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; 2. Department of Medicine, University of Calgary, Calgary, Alberta, Canada; and. 3. The Northern Hospital, Northern Clinical Research Centre, University of Melbourne, Melbourne, Victoria, Australia. 4. Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; swk@ualberta.ca.
Abstract
BACKGROUND AND OBJECTIVES: Unintended injuries or complications in hospitalized patients are common, potentially preventable, and associated with adverse consequences, including greater mortality and health care costs. Patients with CKD may be at higher risk of hospital-acquired complications (HACs). DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Adults from a population-based cohort (Alberta Kidney Disease Network) who were hospitalized from April 1, 2003, to March 31, 2008, made up the study cohort. Kidney function was defined using outpatient eGFR and proteinuria (protein-to-creatinine ratio or dipstick) in the year before index hospitalization. Comorbid conditions were identified using validated algorithms applied to administrative data. A specific diagnostic indicator was used to identify HACs. Complications were classified into clinically homogeneous groups and subclassified as potentially preventable (p-HACs) or always preventable (a-HACs). Multivariable logistic regressions models were used to examine the association of CKD with HACs, accounting for confounders. RESULTS: Of 536,549 patients, 8.5% had CKD; those with CKD were older and more likely to be admitted for circulatory system diseases than those without CKD. In fully adjusted models, the odds ratio (OR) of any hospital complication in patients with CKD (reference: no CKD) was 1.19 (95% confidence interval [95% CI], 1.18 to 1.26); there was a graded relation between the risk of HACs and CKD severity, with an OR of 1.81 (95% CI, 1.51 to 2.17) in those with the most severe CKD (eGFR, 15-29 ml/min per 1.73 m(2) and proteinuria, >30 mg/mmol). Findings were similar for p-HACs (OR, 1.20 [95% CI, 1.16 to 1.24] and 1.78 [95% CI, 1.43 to 2.11], respectively). The a-HACs had similar point estimates. CONCLUSIONS: The presence of CKD and its severity are associated with a higher risk of HACs, including those considered preventable. Targeted strategies to reduce complications in patients with CKD admitted to the hospital should be considered.
BACKGROUND AND OBJECTIVES: Unintended injuries or complications in hospitalized patients are common, potentially preventable, and associated with adverse consequences, including greater mortality and health care costs. Patients with CKD may be at higher risk of hospital-acquired complications (HACs). DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Adults from a population-based cohort (Alberta Kidney Disease Network) who were hospitalized from April 1, 2003, to March 31, 2008, made up the study cohort. Kidney function was defined using outpatienteGFR and proteinuria (protein-to-creatinine ratio or dipstick) in the year before index hospitalization. Comorbid conditions were identified using validated algorithms applied to administrative data. A specific diagnostic indicator was used to identify HACs. Complications were classified into clinically homogeneous groups and subclassified as potentially preventable (p-HACs) or always preventable (a-HACs). Multivariable logistic regressions models were used to examine the association of CKD with HACs, accounting for confounders. RESULTS: Of 536,549 patients, 8.5% had CKD; those with CKD were older and more likely to be admitted for circulatory system diseases than those without CKD. In fully adjusted models, the odds ratio (OR) of any hospital complication in patients with CKD (reference: no CKD) was 1.19 (95% confidence interval [95% CI], 1.18 to 1.26); there was a graded relation between the risk of HACs and CKD severity, with an OR of 1.81 (95% CI, 1.51 to 2.17) in those with the most severe CKD (eGFR, 15-29 ml/min per 1.73 m(2) and proteinuria, >30 mg/mmol). Findings were similar for p-HACs (OR, 1.20 [95% CI, 1.16 to 1.24] and 1.78 [95% CI, 1.43 to 2.11], respectively). The a-HACs had similar point estimates. CONCLUSIONS: The presence of CKD and its severity are associated with a higher risk of HACs, including those considered preventable. Targeted strategies to reduce complications in patients with CKD admitted to the hospital should be considered.
Authors: Teresa M Waters; Michael J Daniels; Gloria J Bazzoli; Eli Perencevich; Nancy Dunton; Vincent S Staggs; Catima Potter; Naleef Fareed; Minzhao Liu; Ronald I Shorr Journal: JAMA Intern Med Date: 2015-03 Impact factor: 21.873
Authors: Nadia A Khan; Hude Quan; Jennifer M Bugar; Jane B Lemaire; Rollin Brant; William A Ghali Journal: J Gen Intern Med Date: 2006-02 Impact factor: 5.128
Authors: Andrew R Paradis; Valerie T Stewart; K Bruce Bayley; Allen Brown; Andrew J Bennett Journal: Am J Med Qual Date: 2009 Jan-Feb Impact factor: 1.852
Authors: G Ross Baker; Peter G Norton; Virginia Flintoft; Régis Blais; Adalsteinn Brown; Jafna Cox; Ed Etchells; William A Ghali; Philip Hébert; Sumit R Majumdar; Maeve O'Beirne; Luz Palacios-Derflingher; Robert J Reid; Sam Sheps; Robyn Tamblyn Journal: CMAJ Date: 2004-05-25 Impact factor: 8.262
Authors: Sarah J Ramer; Nicolas A Baddour; Edward D Siew; Huzaifah Salat; Aihua Bian; Thomas G Stewart; Susan P Y Wong; Manisha Jhamb; Khaled Abdel-Kader Journal: Am J Nephrol Date: 2020-07-28 Impact factor: 3.754
Authors: Sarah J Schrauben; Hsiang-Yu Chen; Eugene Lin; Christopher Jepson; Wei Yang; Julia J Scialla; Michael J Fischer; James P Lash; Jeffrey C Fink; L Lee Hamm; Radhika Kanthety; Mahboob Rahman; Harold I Feldman; Amanda H Anderson Journal: PLoS Med Date: 2020-12-11 Impact factor: 11.069
Authors: Martin Wagner; Christoph Wanner; Martin Schich; Kornelia Kotseva; David Wood; Katrin Hartmann; Georg Fette; Viktoria Rücker; Mehmet Oezkur; Stefan Störk; Peter U Heuschmann Journal: BMC Nephrol Date: 2017-10-25 Impact factor: 2.388
Authors: David José Coca; Sandra Milena Castelblanco; Diego Andrés Chavarro-Carvajal; Luis Carlos Venegas-Sanabria Journal: Biomedica Date: 2021-06-29 Impact factor: 0.935